899PA phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS). (23rd October 2018) - Castellano, D; Duran, I; Rodríguez-Vida, A; Crabb, S J; van der Heijden, M S; Font Pous, A; Gravis, G; Anido Herranz, U; Protheroe, A; Ravaud, A; Maillet, D; Mendez-Vidal, M J; et al.